# US 2015/0338414 A1 · Urea-based synthetic urine and method of manufacturing same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0338414 A1
- Document ID: US20150338414A1
- Status: Published application
- Kind: A1
- Application number: 14/817,642
- Filed: 2015-08-04
- Published: 2015-11-26
- Earliest claimed: 2013-05-06
- Assignees: Spectrum Laboratories, Inc.
- Applicants: Spectrum Laboratories, LLC
- Inventors: James Matthew Stephens
- Web page: https://patentgrep.com/patent/US20150338414A1

## CPC

- G01N 33/62: involving urea
- G01N 33/493: urine
- G01N 33/70: involving creatine or creatinine
- G01N 2496/80: Multi-analyte reference solutions containing cholesterol, glucose and the like
- Y10T 436/10: Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T 436/147777: Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
- Y10T 436/171538: Urea or blood urea nitrogen
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A synthetic urine solution and method of its manufacture are disclosed. The solution includes water having a pH between about 3 and about 10. The solution further includes creatinine, a means for removing bacteria from the solution so as to control or eliminate sepsis of the urine solution, preferably through the use of a biocide, and a urea-based compound. The solution exhibits a specific gravity of from 1.005 g/cm3 to 1.025 g/cm3. Additional compounds may also be included to further enhance the aesthetics or apparent authenticity of the synthetic urine.

## Claims

### Claim 1

A synthetic urine solution comprising:
water having a pH between about 3 and about 10;
creatinine and a biocide, said creatinine and biocide dissolved within said water to form a solution exhibiting a specific gravity and said creatinine and biocide selected in relative concentrations to minimize sepsis;
at least one dissociated ionic compound also dissolved within said solution to adjust the specific gravity of the solution to between 1.005 g/cm3 and 1.025 g/cm3; wherein said biocide is selected from at least one of 2-bromo-4-hydroxyacetophenone, bronopols, carbamates, chlorothioethers, 2-2-Dibromo-3-nitrilopropionamide, 2-(Decylthio)ethanamine, glutaraldehydes, isothiazolines, Methylene bis(thiocyanate), polyquats, Alkyldimethylbenzylammonium chloride, sulfones, bis(tributyltin) oxide, tertbuthylazines, Tetrachloro-2, 4,6-cyano-3-benzonitrile, 2(thiocyanomethylthio)benzothiazole, thiones, Tetrakish(hydroxymethyl)phosphonium sulfate, Tributyltetradecylphosphonium chloride, peroxides, hypochlorites, and super oxides; and
at least one urea compound provided in conjunction with the synthetic urine solution.

### Claim 2 (depends on 1)

The synthetic urine solution of claim 1, wherein the at least one urea compound is either dissolved within said solution or provided separately to be dissolved within said solution at a subsequent time.

### Claim 3 (depends on 1)

The synthetic urine solution of claim 1, wherein the at least one urea compound is selected from at least one of carbamide peroxide, allantoin, and hydantoin.

### Claim 4 (depends on 1)

The synthetic urine solution of claim 1, wherein said at least one ionic compound is selected from at least one of carbonate salts, halide salts, hydroxide salts, and bromides.

### Claim 5

A method of manufacturing a synthetic urine solution comprising:
providing water;
dissolving creatinine and biocide into said water to form a solution exhibiting a specific gravity level, said creatinine and biocide being selected in relative concentrations to minimize sepsis, wherein said biocide is selected from at least one of 2-bromo-4-hydroxyacetophenone, bronopols, carbamates, chlorothioethers, 2-2-Dibromo-3-nitrilopropionamide, 2-(Decylthio)ethanamine, glutaraldehydes, isothiazolines, Methylene bis(thiocyanate), polyquats, Alkyldimethvlbenzylammonium chloride, sulfones, Bis (tributyltin) oxide, tertbuthylazines, Tetrachloro-2,4,6-cyano-3-benzonitrile, 2(thiocyanomethylthio)benzothiazole, thiones, Tetrakish(hydroxymethyl)phosphonium sulfate, Tributyltetradecylphosphonium chloride, peroxides, hypochlorites, and super oxides;
adjusting said specific gravity level of said solution to between 1.005 g/cm3 and 1.025 g/cm3; and
providing at least one urea compound in conjunction with the synthetic urine solution.

### Claim 6 (depends on 5)

The synthetic urine solution of claim 5, wherein the at least one urea compound is either dissolved within said solution or provided separately to be dissolved within said solution at a subsequent time.

### Claim 7 (depends on 5)

The synthetic urine solution of claim 5, wherein the at least one urea compound is selected from at least one of carbamide peroxide, allantoin, and hydantoin.

### Claim 8 (depends on 5)

The method of claim 5 further comprising sealing said synthetic urine solution within a container so as to further minimize sepsis of said synthetic urine solution.

### Claim 9 (depends on 5)

The method of claim 5, further comprising the step of adjusting the pH level of the solution between about 3 and about 10.

### Claim 10

A method of manufacturing a synthetic urine solution comprising:
providing water having a pH between about 3 and about 10;
dissolving creatinine and at least one dissociating ionic compound in the water to form a solution exhibiting a specific gravity, said creatinine and at least one dissociating ionic compound selected in relative concentrations to adjust said specific gravity to between 1.005 g/cm3 and 1.025 g/cm3;
adding a biocide into said solution, said biocide is selected from at least one of 2-bromo-4-hydroxyacetophenone, bronopols, carbamates, chlorothioethers, 2-2-Dibromo-3-nitrilopropionamide, 2-(Decylthio)ethanamine, glutaraldehydes, isothiazolines, Methylene bis(thiocyanate), polyquats, Alkyldimethylbenzylamnionium chloride, sulfones, Bis(tributyltin) oxide, tertbuthylazines, Tetrachloro-2,4,6-cyano-3-benzonitrile, 2(thiocyanomethylthio)benzothiazole, thiones, Tetrakish(hydroxymethyl)phosphonium sulfate, Tributyltetradecylphosphonium chloride, peroxides, hypochlorites, and super oxides;
removing bacteria from said solution;
and providing at least one urea compound in conjunction with the synthetic urine solution.

### Claim 11 (depends on 10)

The synthetic urine solution of claim 10, wherein the at least one urea compound is either dissolved within said solution or provided separately to be dissolved within said solution at a subsequent time.

### Claim 12 (depends on 10)

The synthetic urine solution of claim 10, wherein the at least one urea compound is selected from at least one of carbamide peroxide, allantoin, and hydantoin.

### Claim 13 (depends on 10)

The method of claim 10, further comprising the step of sealing said synthetic urine solution within a container.

### Claim 14 (depends on 11)

The method of claim 11 wherein the step of dissolving creatinine and at least one dissociating ionic compound also includes dissolving the at least one urea compound in the water, said at least one urea compound selected in a concentration relative to that of said creatinine and at least one dissociating ionic compound so as to maintain the specific gravity of the solution between 1.005 g/cm3 and 1.025 g/cm3.

### Claim 15 (depends on 14)

The method of claim 14, further comprising the step of sealing said synthetic urine solution within a container.

### Claim 16 (depends on 10)

The method of claim 10, wherein the bacteria are removed from said solution using an in situ agent selected from at least one of ozone, dioxides, ultraviolet radiation, and irradiation processes followed by hermetic sealing of the solution.
